Market Tracker

10/24 6:05pm ET

Halozyme Therapeutics Inc (NASDAQ:HALO)

9.15
Data as of Oct 24
 -0.11 / -1.19%
Today’s Change
6.88
Today|||52-Week Range
18.18
-38.96%
Year-to-Date

Today’s Trading

Previous close9.26
Today’s open9.23
Day’s range9.10 - 9.46
Volume1,167,576
Average volume (3 months)1,320,532
Market cap$1.2B
Dividend yield--
Data as of 3:59pm ET, 10/24/2014

Growth & Valuation

Earnings growth (last year)-54.17%
Earnings growth (this year)+13.68%
Earnings growth (next 5 years)--
Revenue growth (last year)+29.47%
P/E ratioNM
Price/Sales30.86
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NVAXNovavax Inc+0.14+2.81%
BLUEbluebird bio Inc+1.67+4.25%
KITEKite Pharma Inc-0.60-1.77%
OPHTOphthotech Corp-0.12-0.30%
Data as of 3:59pm ET, 10/24/2014

Financials

Next reporting dateNovember 7, 2014
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$54.8M
Annual profit (last year)-$83.5M
Net profit margin-152.33%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts